Neurocrine Bioscience buy Barclays PLC
Start price
02.05.24
/
50%
€131.25
Target price
02.05.25
€157.54
Performance (%)
-26.05%
End price
03.05.25
€97.06
Summary
This prediction ended on 03.05.25 with a price of €97.06. The prediction for Neurocrine Bioscience disappointed with a performance of -26.05%. Barclays_PLC has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -1.724% | -1.724% | 3.473% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $150.00 to $169.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.85
23.12.24
23.12.24
€158.60
23.12.25
23.12.25
-6.97%
22:26
22:26
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.95
09.09.24
09.09.24
€144.91
09.09.25
09.09.25
10.87%
10.09.25
10.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.00
02.08.24
02.08.24
€164.74
02.08.25
02.08.25
-20.29%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
8.44%
24.01.25
24.01.25